Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs Vida Health

Mevo Health
Graded #326

Higher grade

vs+5
Vida Health
Graded #446

Lower grade

The verdict

Mevo Health takes it — 60.2/100 to 55.2/100.

Mevo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMevo Health +11
56
45
Dose & formulationMevo Health +43
83
40
Clinical oversightVida Health +8
67
75
Labs & monitoringVida Health +9
52
61
FulfillmentVida Health +5
57
62
Contract termsVida Health +35
20
55
Mevo Health · left barVida Health · right bar

The numbers

MetricMevo HealthVida Health
WeighScore60.2/10055.2/100
GradeCC
Scorecard rank#326#446
Semaglutide$199/mo (all doses, compounded)Not disclosed
Tirzepatide$259/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
Vida Health

Graded #446 · C

Strengths

  • Medical Weight Loss program includes anti-obesity GLP-1 medications
  • Pairs medication with behavioral-health coaching and medical management
  • Whole-person care across chronic conditions, sleep, and nutrition
  • Integrates with major health plans, PBMs, and benefit platforms
  • Established virtual chronic-care platform

Where it loses points

  • Distributed mainly via employers and health plans, not direct cash-pay
  • Access usually requires employer or plan sponsorship
  • No public consumer GLP-1 pricing
  • Clinician credentials not detailed publicly
  • Less suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard